TrialClinical and vaccine immunology : CVI2014

A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato.

Nina Wressnigg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.